Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
Clinical trial NCT04552418 · COMPLETED
Trial details
- NCT number
- NCT04552418
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2023-01-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.